Transcutaneous auricular vagus nerve stimulation as a potential therapy for attention deficit hyperactivity disorder: modulation of the noradrenergic pathway in the prefrontal lobe
Zhi J, Zhang S, Huang M, Qin H, Xu H, Chang Q, Wang Y
Frontiers in Neuroscience · 2024
Key finding
In recent years, transcutaneous auricular vagus nerve stimulation (taVNS), a non-invasive neuromodulation technique, has demonstrated promising potential in the treatment of neurological and psychiatric disorders.
- Condition
- ADHD
- Stimulation
- taVNS
- Evidence tier
- Controlled Clinical Trial
- Participants
- —
Cite this study
Zhi, J., Zhang, S., Huang, M., Qin, H., Xu, H., Chang, Q., & Wang, Y. (2024). Transcutaneous auricular vagus nerve stimulation as a potential therapy for attention deficit hyperactivity disorder: modulation of the noradrenergic pathway in the prefrontal lobe. Frontiers in Neuroscience, 18. https://doi.org/10.3389/fnins.2024.1494272
Related studies in ADHD
Towards optimizing target engagement in non-invasive trigeminal nerve stimulation: anatomical characterization of the human trigeminal nerve
Perrault et al. · Journal of neural engineering · 2025 · Controlled Clinical Trial
Transcutaneous vagus nerve stimulation in patients with attention-deficit/hyperactivity disorder: A viable option?
Zaehle et al. · Progress in brain research · 2021 · Controlled Clinical Trial
Epilepsy Disorders and Treatment Modalities
Kaeberle · NASN school nurse (Print) · 2018 · Controlled Clinical Trial
Emerging brain-based interventions for children and adolescents: overview and clinical perspective
Hirshberg et al. · Child and adolescent psychiatric clinics of North America · 2005 · Controlled Clinical Trial
Summary by Vagus Research. Always consult the primary source for the authoritative record.